Further analysis stratified by CVD subtypes (stroke, PAOD, heart failure, arrhythmia, cerebrovascular accident, and coronary artery disease) revealed that IFN‐based therapy and attainment of SVR were not significantly associated with CVD event rates across any subtype (Figure 2b–g, Table 2). The gene discussed is IFNA1; the disease is coronary artery disorder.